Table 2. Primary and assisted clinical success at 1 month in the present series.
| Total patients 122 | |
| Primary clinical success (n; %) | 118; 96.8% |
| Aneurysm-related death | 0 |
| Type I or III endoleak* | 2; 1.6% |
| Aneurysm expansion* | 0 |
| Graft infection | 0 |
| Graft thrombosis* | 2; 1.6% |
| Conversion to open repair | 0 |
| Assisted primary clinical success (n; %) | 120; 98.4% |
| Aneurysm-related death | 0 |
| Type I or III endoleak* | 0 |
| Aneurysm expansion* | 0 |
| Graft infection | 0 |
| Graft thrombosis* | 2**; 1.6% |
| Conversion to open repair | 0 |
| * assessed by CT and/or ultrasound follow-up. ** asymptomatic iliac limb occlusion, medically managed. | |